StockData
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. (MCRB) stock

MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$1.44+0.03 (+2.13%)

Close on Nov 18, 2026Market cap $14.32MP/E –Yield –

Seres Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Seres Therapeutics's price to sales ratio was 7.8× on Nov 11, 2026, against 449.2× a year earlier. Over the last 5 years it ranged from 0.9× to 449.2×, with a median of 50.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.8×−363.7
2025Dec 31, 2025371.6×+39.2
2024Oct 31, 2024332.4×+331.0
2023Dec 29, 20231.4×−50.7
2022Dec 30, 202252.1×+47.2
2021Dec 31, 20214.9×−91.1
2020Dec 31, 202096.0×+89.6
2019Dec 31, 20196.4×−2.5
2018Dec 31, 20188.9×−3.9
2017Dec 29, 201712.8×−8.5
2016Dec 30, 201621.3×–

More Seres Therapeutics figures

See a number that looks wrong?